Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL522758 | 0.80 | EGLN1 (0.84) | EGLN2EGLN1 | |
| SCHEMBL15268444 | 0.80 | EGLN2 (0.65) | EGLN2EGLN1 | |
| SCHEMBL5314140 | 0.80 | EGLN2 (0.62) | EGLN2EGLN1 | |
| SCHEMBL5314146 | 0.80 | EGLN2 (0.62) | EGLN2EGLN1 | |
| SCHEMBL15268493 | 0.77 | EGLN2 (1.00) | EGLN2EGLN1 | |
| SCHEMBL15268661 | 0.76 | EGLN2 (1.00) | EGLN2EGLN1 | |
| SCHEMBL522048 | 0.76 | EGLN2 (0.59) | EGLN2EGLN1 | |
| SCHEMBL523000 | 0.75 | EGLN2 (0.70) | EGLN2EGLN1 | |
| SCHEMBL523001 | 0.75 | EGLN2 (0.70) | EGLN2EGLN1 | |
| SCHEMBL15268934 | 0.75 | EGLN2 (1.00) | EGLN2EGLN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1893186-A2 | IMPROVED TREATMENT FOR ANEMIA USING A HIF-ALPHA STABILISING AGENT | FIBROGEN, INC. (US) | 2008-03-05 | — | — | EP | disclosed |
| WO-2007146425-A2 | COMPOUNDS AND METHODS FOR TREATMENT OF CHEMOTHERAPY-INDUCED ANEMIA | FIBROGEN, INC. (US) | 2007-12-21 | — | — | WO | disclosed |
| WO-2006133391-A2 | IMPROVED TREATMENT FOR ANEMIA USING A HIF-ALPHA STABILISING AGENT | FIBROGEN, INC. (US) | 2006-12-14 | — | — | WO | disclosed |